Linnaeus Therapeutics, Inc. (“Linnaeus”), a privately held biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, today announced that preclinical data from studies conducted at the University of Pennsylvania by its scientific founders was published in the journal eLife.
Reduced side effects of medicine Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]
Why the flu virus don't spread as you might expect Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices [...]
Consistent testing cannot fail Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]
Alternative science and the benefits Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla diam placerat ipsum. Donec [...]
What has modern medicine learnt from humans in space? Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla [...]
What we know about the structures of human brain (and what we don't) Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum [...]
To what extent can you influence your families genetics? Results are encouraging Aenean vitae neque est. Proin aliquam, lacus non ullamcorper elementum, diam eros faucibus orci, sed lobortis lectus urna egestas ligula. Morbi viverra, orci ac sodales consectetur, erat justo dictum urna, sodales ultrices nulla [...]
Linnaeus Therapeutics Awarded $300,000 Phase 1 STTR by National Cancer Institute Haddonfield NJ, March 16, 2018--Linnaeus Therapeutics, Inc. (“Linnaeus”), a privately held biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, today announced it has been awarded a Phase 1 Small Business [...]
Linnaeus Therapeutics, Inc. (“Linnaeus”), a privately held biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, today announced that data from studies conducted at the University of Pennsylvania by its scientific founders was published in the journal eLife.
